The federal raid on Aldridge BioHealth headquarters was nothing short of cinematic. It happened during a noon board meeting, a moment of high-stakes corporate strategizing.
I sat in Clara’s modest car, parked discreetly down the street, watching the live news coverage unfold on her phone. My grand jury deposition, coupled with Clara’s meticulously gathered digital server evidence, had ignited a firestorm.
Black SUVs with federal seals screamed up to the glittering glass tower of Aldridge BioHealth. Agents, precise and unyielding, stormed the building. The news choppers were already circling, their blades chopping at the air.
Inside, Julian, in the middle of a presentation on the impending $400 million acquisition, was abruptly interrupted. Footage, shaky but clear, showed federal agents entering the boardroom.
Marcus Bennett’s face, usually so composed, contorted in a mixture of shock and anger.
Julian, still holding a laser pointer, his mouth open, was confronted. Without a word, he was handcuffed in front of his entire executive board, his face draining of color. He offered no resistance.
The news anchor’s voice, a breathless monotone, listed the charges: “Eight counts of major pharmaceutical fraud. Multiple SEC violations. Federal obstruction.”
The stock ticker on the bottom of the screen flickered wildly. ALDR plunged. Sixty-eight percent in two hours. The $400 million corporate buyout, Julian’s life’s work, collapsed in an instant.
I watched, numb, as they led my son away, his head held high, though his shoulders seemed to sag under the weight of the cuffs.
“Justice,” I whispered, the word feeling strange on my tongue. “It’s finally here.”
Clara reached over and squeezed my hand, her eyes still on the screen, a complex mix of relief and sorrow in their depths. I thought I had won. I thought the nightmare was over. But a gnawing uneasiness, a cold finger of doubt, still brushed against my soul.
+ There are no comments
Add yours